logo

ITI Pharma and Healthcare Reg IDCW-R

0

0.00(0%)
NAV as of . Log in to view Live prices
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Scheme Information

Logo

ITI Pharma and Healthcare Reg IDCW-R

as of 08 May 2026, 15:18 PM

Scheme Asset Size₹211.30 Cr
Expense Ratio2.35%
Cash Holding0.80483%
Fund TypeOpen-End
PlanDividend
BenchmarkNifty Healthcare TR INR
Launch Date2021-11-11
Exit LoadExit load of 0.50% for investments if redeemed within 3 Months

SIP Calculator

12%
₹5,000
₹500₹10,00,000
10 Years
1 Year40 Years
Invested Amount
Estimated Return

Invested Amount

₹6,00,000

Est. Return

₹5,61,695

Total Value

₹11,61,695

Invested Amount
Estimated Return
Invest Now

Scheme Ratings

-

rated by Value Research

Scheme Riskometer

Your principal will be at Very High Risk

Investment Returns

Absolute Returns

CAGR

In the last 1 months 12.15%
In the last 3 months 12.11%
In the last 6 months 1.92%
In the last 1 Years 5.14%
In the last 3 Years 0.77%
In the last 5 Years 0.00%

Company Holdings

Company Name
Sector
Instrument
Assets
Sun Pharmaceuticals Industries LtdHealthcareE11.80%
Divi's Laboratories LtdHealthcareE8.77%
Apollo Hospitals Enterprise LtdHealthcareE6.60%
Max Healthcare Institute Ltd Ordinary SharesHealthcareE5.50%
Torrent Pharmaceuticals LtdHealthcareE5.28%
Aurobindo Pharma LtdHealthcareE4.99%
Lupin LtdHealthcareE4.20%
Laurus Labs LtdHealthcareE3.65%
Alkem Laboratories LtdHealthcareE3.12%
Fortis Healthcare LtdHealthcareE2.91%
Neuland Laboratories LtdHealthcareE2.66%
Aster DM Healthcare Ltd Ordinary SharesHealthcareE2.32%
Abbott India LtdHealthcareE2.32%
Glenmark Pharmaceuticals LtdHealthcareE2.15%
Cohance Lifesciences LtdHealthcareE2.09%
Dr Reddy's Laboratories LtdHealthcareE1.87%
Mankind Pharma LtdHealthcareE1.85%
Sai Life Sciences LtdHealthcareE1.82%
Ipca Laboratories LtdHealthcareE1.70%
Cipla LtdHealthcareE1.67%
Park Medi World LtdHealthcareE1.49%
Linde India LtdBasic MaterialsE1.39%
Biocon LtdHealthcareE1.29%
SBI Life Insurance Co LtdFinancial ServicesE1.25%
HealthCare Global Enterprises LtdHealthcareE1.24%
Sumitomo Chemical India Ltd Ordinary SharesBasic MaterialsE1.21%
FDC LtdHealthcareE1.16%
OneSource Specialty Pharma LtdHealthcareE1.15%
Rainbow Childrens Medicare LtdHealthcareE1.11%
Shaily Engineering Plastics LtdBasic MaterialsE1.11%
Piramal Pharma LtdHealthcareE1.10%
Jubilant Ingrevia Ltd Ordinary SharesBasic MaterialsE1.06%
GlaxoSmithKline Pharmaceuticals LtdHealthcareE1.00%
Orchid Pharma LtdHealthcareE0.83%
Shilpa Medicare LtdHealthcareE0.82%
Standard Engineering Technology LtdIndustrialsE0.82%
Caplin Point Laboratories LtdHealthcareE0.74%
Zydus Lifesciences LtdHealthcareE0.69%
AstraZeneca Pharma India LtdHealthcareE0.69%
Poly Medicure LtdHealthcareE0.68%
Supriya Lifescience LtdHealthcareE0.67%
Syngene International LtdHealthcareE0.41%
Net Receivables / (Payables)-C0.80%

Sector Holding Analysis

Equity / Debt / Cash Split

Loading chart…

Equity

99.2%

Cash

0.8%

Equity sector allocation

Loading chart…

Basic Materials

4.77%

Financial Services

1.25%

Healthcare

92.36%

Industrials

0.82%

Others

0.8%

Fund House Contact Details

Websitewww.itimf.com
Phone022-66214999
Logo
ITI Asset Management Limited

Asset Management Company

About ITI Pharma and Healthcare Reg IDCW-R

Investment Objective of the Scheme

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.

Key Features of The Fund

5-year return

-

Fund Manager

Dhimant Shah

Risk Profile

Very High Risk

Expense Ratio

2.35%

Fund Size

₹211.30 Cr

FAQ's

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy